Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

Clinical trial NCT00805350 · COMPLETED

Trial details

NCT number: NCT00805350
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Insomnia

Start date: 2008-12-01
Primary completion: 2009-06-01
Enrollment: 637

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.